New Angina Drug Reaches Market

French firm Servier has launched Coralan (ivabradine) in Singapore for the treatment of angina. Because of the city state's affluence and the increasing burden of cardiovascular disease, BMI expects the product to perform well, especially if the drug is approved for additional indications such as heart failure. However, revenue will be limited by Singapore's small population.

To read the full article, please choose one of the following options: